CT, MR imaging, and radionuclide imaging in a patient with hepatic involvement in primary amyloidosis.
Ohta
H
H
Department of Laboratories, Osaka Red Cross Hospital, Japan.
Kokuryu
H
H
Ota
T
T
Tomono
N
N
Shimizu
T
T
Shintaku
M
M
Komibuchi
T
T
D000686:Amyloidosis / Q000175:diagnosis / Q000000981:diagnostic imaging*; D006801:Humans; D008099:Liver / Q000000981:diagnostic imaging*; D008107:Liver Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D010833:Phytic Acid; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D016284:Technetium Tc 99m Pentetate; D016698:Technetium Tc 99m Pyrophosphate; D014057:Tomography, X-Ray Computed
D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; C070561:technetium Tc 99m DTPA-galactosyl-human serum albumin; C026177:technetium phytate; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D016698:Technetium Tc 99m Pyrophosphate; D010833:Phytic Acid; D016284:Technetium Tc 99m Pentetate